Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's disease
- PMID: 10203348
- DOI: 10.1097/00001756-199902050-00040
Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's disease
Abstract
A coding substitution (I93M) in the ubiquitin carboxy-terminal L1 (UCH-L1) gene has recently been identified in a German family with Parkinson's disease. We have sequenced the entire coding region of the gene in 11 families who have a pattern of disease consistent with autosomal dominant inheritance. We found a polymorphism (S18Y) in exon 3, two polymorphisms in the 5' non-coding region, upstream of the transcription start, and an insertion/deletion polymorphism in intron 4. The S18Y allele is present on approximately 20% of chromosomes in a Caucasian population. These changes are, therefore, unlikely to be pathogenic. We conclude that the I93M variant must either be a rare cause of disease or a harmless substitution whose occurrence in the family reflects a chance co-occurrence.
Similar articles
-
The ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism does not confer protection against idiopathic Parkinson's disease.Neurosci Lett. 2000 Oct 27;293(2):127-30. doi: 10.1016/s0304-3940(00)01510-x. Neurosci Lett. 2000. PMID: 11027850
-
No genetic association of the ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism with familial Parkinson's disease.J Neural Transm (Vienna). 2001;108(8-9):979-84. doi: 10.1007/s007020170017. J Neural Transm (Vienna). 2001. PMID: 11716150
-
Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease.Neurology. 1999 Nov 10;53(8):1858-60. doi: 10.1212/wnl.53.8.1858. Neurology. 1999. PMID: 10563640
-
Genetics of Parkinson's disease.Ann N Y Acad Sci. 2000;920:28-32. doi: 10.1111/j.1749-6632.2000.tb06901.x. Ann N Y Acad Sci. 2000. PMID: 11193165 Review.
-
Familial Mutations and Post-translational Modifications of UCH-L1 in Parkinson's Disease and Neurodegenerative Disorders.Curr Protein Pept Sci. 2017;18(7):733-745. doi: 10.2174/1389203717666160217143721. Curr Protein Pept Sci. 2017. PMID: 26899237 Review.
Cited by
-
The genetics of Parkinson's disease.Curr Neurol Neurosci Rep. 2002 Sep;2(5):439-46. doi: 10.1007/s11910-002-0071-9. Curr Neurol Neurosci Rep. 2002. PMID: 12169225 Review.
-
USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.J Biol Chem. 2009 Apr 3;284(14):9587-95. doi: 10.1074/jbc.M807216200. Epub 2009 Feb 2. J Biol Chem. 2009. PMID: 19188362 Free PMC article.
-
Ubiquitin C-terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats.Eur J Neurosci. 2010 Feb;31(4):722-32. doi: 10.1111/j.1460-9568.2010.07097.x. Eur J Neurosci. 2010. PMID: 20384815 Free PMC article.
-
Ubiquitin C-terminal Hydrolase L1 Regulates Lipid Raft-dependent Endocytosis.Exp Neurobiol. 2018 Oct;27(5):377-386. doi: 10.5607/en.2018.27.5.377. Epub 2018 Oct 31. Exp Neurobiol. 2018. PMID: 30429647 Free PMC article.
-
Transgenic animal models of neurodegeneration based on human genetic studies.J Neural Transm (Vienna). 2011 Jan;118(1):27-45. doi: 10.1007/s00702-010-0476-6. Epub 2010 Oct 8. J Neural Transm (Vienna). 2011. PMID: 20931247 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous